BioCardia
BCDA
9 hedge funds and large institutions have $700K invested in BioCardia in 2019 Q3 according to their latest regulatory filings, with 9 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
0.2% more ownership
Funds ownership: 0% → 0.2% (+0.2%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LTFS
Ladenburg Thalmann Financial Services
Miami,
Florida
|
+$441K |
| 2 |
Millennium Management
New York
|
+$201K |
| 3 |
Brown Advisory
Baltimore,
Maryland
|
+$158K |
| 4 |
Goldman Sachs
New York
|
+$98.9K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$73.3K |
Top Sellers
BCDA Hedge Fund Activity: Q3 2019 in Review
9 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in BioCardia (BCDA) for Q3 2019, worth a combined $700K.
Buyers outnumbered sellers: 9 funds opened new BCDA positions and 0 closed out — a net gain of 9 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Ladenburg Thalmann Financial Services, opening a new position worth an estimated $441K.
- 9 institutional investors held BioCardia (BCDA) as of Q3 2019, up from 0 in Q2 2019.
- Funds reported $700K of BioCardia stock for Q3 2019.
- 9 funds opened new BioCardia positions in Q3 2019 and 0 closed out, a net change of +9 holders.
- The largest BioCardia buyer in Q3 2019 was Ladenburg Thalmann Financial Services, an estimated $441K added.
Based on aggregated 13F filings for Q3 2019.